Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere(R) (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.
U-M expert says new cancer treatments, technologies give women more hope of preserving fertility. Once Alyssa Tushman knew her young son would not grow up motherless, her next question was whether he would be an only child.
Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), in response to inaccurate and misleading media reports surrounding the U.S. Food and Drug Administration’s upcoming joint meeting of the Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee scheduled for October 18 and 19:
UT Southwestern Medical Center has been selected to take part in an $11.5 million multicenter clinical trial that is examining the effectiveness of induced hypothermia as a therapy for brain swelling in children who have suffered severe traumatic brain injuries.
The Rhode Island Department of Health (HEALTH) announces that the state-wide start date for adult flu shots will be Wednesday, October 17, 2007.
MIT researchers have developed a new algorithm to help create prosthetic devices that convert brain signals into action in patients who have been paralyzed or had limbs amputated.
Until October_27, 2007, the Federal Trade Commission will be accepting refund requests from consumers who bought CortiSlim or CortiStress. The FTC alleged that CortiSlim was advertised with false and unsubstantiated weight loss claims and that CortiStress was advertised with false and unsubstantiated disease prevention claims.
An estimated one million people in Wisconsin, and 16 percent of all Americans, are suffering from depression — and many don’t recognize the symptoms or know where to turn for help.
A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.
Among Medicare patients, men are about 2-3 times more likely than women to receive an implantable cardioverter-defibrillator for the prevention of sudden cardiac death, according to a study in the October 3 issue of JAMA.